Meghan Delaney Meghan Delaney
Professor of Pathology
Professor of Pediatrics (Secondary)

Office Phone: 202-476-5124
Email: Email
Department: Pathology

Education

  • BS Biology, University of Vermont, 1998
  • Doctor of Osteopathic Medicine (DO), University of New England Col of Osteo Med, 2004
  • MPH, University of Washington School of Public Health, 2010

Biography

Meghan Delaney is the Chief of the Division of Pathology & Laboratory Medicine and the Director of Transfusion Medicine at Children’s National Hospital and she is a Professor of Pathology and Pediatrics and the George Washington University.  Delaney received a bachelor’s degree in biology from University of Vermont, a Master of Public Health from University of Washington and osteopathic medical degree from University of New England. She completed her clinical pathology residency at Beth Israel Deaconess / Harvard Medical School and transfusion medicine fellowship at Bloodworks NW (formerly Puget Sound Blood Center) in Seattle, WA. She serves as the president elect of the Board of Directors for AABB and is a Board Member of the BEST Collaborative and is a member of the American Board of Pathology Test Development and Advisory Committee.  

Clinical Expertise

Delaney’s focus is in clinical pathology, laboratory management, transfusion medicine, pediatric transfusion medicine and immunohematology.  In global health, Delaney focuses on improving access to safe blood transfusion in low and middle income nations.     

Research

Delaney has authored over 120 peer reviewed publications and book chapters and reviews.  She lectures nationally and internationally about transfusion medicine topics.  Delaney is an Associate Editor for Transfusion Medicine and on the editorial board for the journal Transfusion and Transfusion Medicine Reviews.  In global health, Delaney focuses on improving access to safe blood transfusion in developing nations through healthcare systems strengthening projects, education and technology development.  She serves as the Chair of NIH’s BLOODSAFE Program that aims to improve access to safe blood in Sub Saharan Africa. 

Teaching

Transfusion Medicine
Global Health
Laboratory Management

Publications

Delaney M, Telke S, Zou S, Williams MJ, Aridi JO, Rudd KE, Puyana JC, Kumar P, Appiah B, Dei-Adomakoh Y, Asamoah-Akuoko L, Olayemi E, Singogo E, Hosseinipour MC, M'baya B, Chipeta E, Reilly C; BLOODSAFE Program Investigators. The BLOODSAFE program: Building the future of access to safe blood in Sub-Saharan Africa. Transfusion. 2022 Sep 29. PMID: 36173295.

Delaney M, Oveland Apelseth T, Bonet Bub C, Cohn CS4, Dunbar NM, Kutner JM, Murphy M, Perelman I, Selleng K, Staves J, Wendel S, Ziman A, on behalf of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Red Blood Cell Alloimmunization and Prophylactic Antigen Matching for Transfusion in Patients with Warm Autoantibodies. Vox Sang. 2020 Aug;115(6):515-524. PMID: 32249930.

Roberts N, James S, Delaney M, Fitzmaurice C. The Global Need and Availability of Blood Products: A modeling study. Lancet Haematology. 2019. S2352-3026(19)30200-1. PMID: 31631023.

Delaney M, Wikman A, van de Watering L, Schonewille H, Verdoes JP, Emery SP, Murphy MF, Staves J, Flach S, Arnold DM, Kaufman RM, Ziman A, Harm SK, Fung M, Eppes CS, Dunbar NM, Buser A, Meyer E, Savoia H, Abeysinghe P, Heddle N, Tinmouth A, Traore AN, Yazer MH, for the BEST Collaborative. Blood Group Antigen Matching Influence on Gestational Outcomes (AMIGO) Study. Transfusion. 2017 Mar;57(3):525-532. PMID: 28164304

Delaney M, Mayock D, Knezevic A, Norby-Slycord C, Kleine E, Patel R, Easley K, Josephson C. Postnatal CMV infection: A pilot comparative effectiveness study of transfusion safety using leukoreduced only transfusion strategy. Transfusion, 2016 Aug;56(8):1945-50. PMID: 27080192

Delaney M, Wendel S, Bercovitz RS, Cid J, Cohn C, Dunbar NM, Apelseth TO, Popovsky M, Stanworth SJ, Tinmouth A, Van De Watering L, Waters JH, Yazer M, Ziman A, for the Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Transfusion reactions: prevention, diagnosis, and treatment. The Lancet, 2016, Dec 3;388(10061):2825-2836. PMID: 27083327

Sandler SG, Flegel WA, Westhoff CM, Denomme GA, Delaney M, Keller MA, Johnson ST, Katz L, Queenan JT, Vassallo RR, Simon CD. It’s time to phase-in RHD genotyping for patients with a serological weak D phenotype. Transfusion. 2015 Mar; 55(3):680-9. PMID: 25438646

Steiner ME, Ness PM, Assmann SF, Triulzi DJ, Sloan SR, Delaney M, Granger S, Bennett-Guerrero E, Blajchman MA, Scavo V, Carson JL, Levy JH, Whitman G, D’Andrea P, Pulkrabek S, Ortel TL, Bornikova L, Raife T, Puca KE, Kaufman RM, Nuttall GA, Young PP, Youssef S, Engelman R, Greilich PE, Miles R, Josephson CD, Bracey A, Cooke R, McCullough J, Hunsaker R, Uhl L, McFarland JG, Park Y, Cushing MM, Klodell, KR, Roberts PR, Dyke C, Hod EA, Stowell CP. Effects of Red Cell Storage Duration in Cardiac Surgery Patients. New England Journal of Medicine. 2015 Apr 9;372(15):1419-29. PMID: 25853746

Industry Relationships and Collaborations

This faculty member (or a member of their immediate family) has reported a financial interest with the health care related companies listed below. These relations have been reported to the University and, when appropriate, management plans are in place to address potential conflicts.

  • None